842 results on '"McGuigan C"'
Search Results
102. ChemInform Abstract: Phosphoramidate Derivatives of 2′,3′-Didehydro-2′,3′-dideoxyadenosine ( d4A) Have Markedly Improved Anti-HIV Potency and Selectivity.
103. Do the Wright thing.
104. Apres Mickey, le deluge.
105. Spain's back on track.
106. The perfectionist.
107. A renegade takes the prize.
108. High style in the 'burbs.
109. Transforming the landscape.
110. The quiet revolutionary.
111. FV100 as a new approach for the possible treatment of varicella-zoster virus infection
112. In Vitro Activity and In Vivo Pharmacokinetics of Highly Potent Phosphoramidate Nucleoside Analogue Inhibitors of Hepatitis C NS5B
113. Spinal claudication due to myxopapillary ependymoma
114. Campylobacter Immunity and Coinfection following a Large Outbreak in a Farming Community
115. Design and Synthesis of Novel Non-nucleoside Anti-HCMV Agents
116. Molecular Modelling Studies on the Binding of Some Protides to the Putative Human Phosphoramidase Hint1
117. Spinal claudication due to myxopapillary ependymoma
118. The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite
119. Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus
120. The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical)
121. Design, Synthesis, and Biological Evaluation of Novel Anti-VZV Agents
122. HINT as Putative Phosphoramidase Responsible of ProTides Activation: Molecular Modelling Studies
123. The Design, Synthesis and Anti-HIV Activity of a Selected Group of 2′,3′-Didehydro-2′,3′-Dideoxyguanosine (d4G) and 2′,3′-Dideoxyguanosine (ddG) ‘ProTide’ Derivatives
124. Sub Micromolar Inhibitors of HCV Generated from Inactive Nucleosides by Application of ProTide Technology
125. Design and Synthesis of Novel Anti-HCMV Agents: Modifications to the Bicyclic Pyrimidine Base
126. Topical Delivery of Retinyl Ascorbate Co-Drug
127. A synovial cyst in the cervical spine causing acute spinal cord compression
128. Unrecognised symptoms of depression in a community–based population with multiple sclerosis
129. Encephalopathy in a patient with previous malignancy but normal brain imaging
130. Cryptosporidium outbreak after a visit to a wildlife centre in northeast Scotland: 62 confirmed cases
131. NAPHTHYL PHOSPHORAMIDATE DERIVATIVES OF BVdU AS POTENTIAL ANTICANCER AGENTS: DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION
132. THE JOURNEY TOWARDS ELUCIDATING THE ANTI-HCMV ACTIVITY OF ALKYLATED BICYCLIC FURANO PYRIMIDINES
133. PHOSPHORAMIDATE DERIVATIVES OF 2′,5′-DIDEOXYADENOSINE AS POTENTIAL INHIBITORS OF THE EDHF PHENOMENON
134. SYNTHESIS AND BIOLOGICAL EVALUATION OF N- AND O-ALKYLATED BICYCLIC FURANOPYRIMIDINES AS NON-NUCLEOSIDIC INHIBITORS OF HUMAN CYTOMEGALOVIRUS
135. Severe illness and death among injecting drug users in Scotland: a case-control study
136. Confirming the validity and responsiveness of the Multiple Sclerosis Walking Scale-12 (MSWS-12)
137. Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase
138. Synthesis of Unusual Bicyclic Nucleosides Bearing an Unsaturated Side-Chain, as Potential Inhibitors of Varicella—Zoster Virus (VZV)
139. Bicyclic Nucleoside Inhibitors of Varicella—Zoster Virus: 5′‐Chloro and 3′‐Chloro Derivatives
140. Metabolic and Pharmacological Characteristics of the Bicyclic Nucleoside Analogues (BCNAs) as Highly Selective Inhibitors of Varicella—Zoster Virus (VZV)
141. Bicyclic Nucleoside Inhibitors of Varicella—Zoster Virus: Synthesis and Biological Evaluation of 2′,3′‐Dideoxy‐3′‐fluoro and 2′‐Deoxy‐xylo Derivatives
142. Topical Delivery of Retinyl Ascorbate Co-Drug
143. Bicyclic Nucleoside Inhibitors of Varicella-Zoster Virus: Synthesis and Biological Evaluation of 2′,3′-Dideoxy- 3′-fluoro and 2′-Deoxy-xylo Derivatives
144. Metabolic and Pharmacological Characteristics of the Bicyclic Nucleoside Analogues (BCNAs) as Highly Selective Inhibitors of Varicella-Zoster Virus (VZV)
145. Bicyclic Nucleoside Inhibitors of Varicella-Zoster Virus: 5′-Chloro and 3′-Chloro Derivatives
146. Synthesis of Unusual Bicyclic Nucleosides Bearing an Unsaturated Side-Chain, as Potential Inhibitors of Varicella-Zoster Virus (VZV)
147. Case report: Recurrent temporalis muscle swelling and headache
148. Bicyclic Nucleoside Inhibitors of Varicella-Zoster Virus: Effect of Terminal Aryl Substitution in the Side-Chain
149. Complex regional pain syndrome post mastectomy
150. Synthesis and Antiviral Evaluation of Phosphoramidate Derivatives of (E)-5-(2-Bromovinyl)-2′-Deoxyuridine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.